Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A comprehensive analysis of the relationship between ACA velocities and ACA infarction following aneurysmal subarachnoid hemorrhage.

Moussouttas M, Cheng J, Antonakakis J, Patel A, Iuanow M.

J Neurol Sci. 2017 May 15;376:143-150. doi: 10.1016/j.jns.2017.03.024. Epub 2017 Mar 18.

PMID:
28431602
2.

Silent Cerebral Small Vessel Disease in Restless Legs Syndrome.

Ferri R, Cosentino FI, Moussouttas M, Lanuzza B, Aricò D, Bagai K, Wang L, McLaughlin B, Walters AS.

Sleep. 2016 Jul 1;39(7):1371-7. doi: 10.5665/sleep.5966.

3.

Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy.

Moussouttas M, Mearns E, Walters A, DeCaro M.

Cerebrovasc Dis Extra. 2015 Jun 10;5(2):57-67. doi: 10.1159/000431155. eCollection 2015 May-Aug.

4.

Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome.

Riley K, Yampolsky N, Hakma Z, Moussouttas M.

Am J Health Syst Pharm. 2015 Apr 15;72(8):632-5. doi: 10.2146/ajhp140343.

PMID:
25825186
5.

The incidence and risk factors of associated acute myocardial infarction (AMI) in acute cerebral ischemic (ACI) events in the United States.

Seifi A, Carr K, Maltenfort M, Moussouttas M, Birnbaum L, Parra A, Adogwa O, Bell R, Rincon F.

PLoS One. 2014 Aug 28;9(8):e105785. doi: 10.1371/journal.pone.0105785. eCollection 2014.

6.

The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States.

Seifi A, Asadi-Pooya AA, Carr K, Maltenfort M, Emami M, Bell R, Moussouttas M, Yazbeck M, Rincon F.

Springerplus. 2014 Jul 1;3:332. doi: 10.1186/2193-1801-3-332. eCollection 2014.

7.

Association between acute sympathetic response, early onset vasospasm, and delayed vasospasm following spontaneous subarachnoid hemorrhage.

Moussouttas M, Lai EW, Huynh TT, James J, Stocks-Dietz C, Dombrowski K, Khoury J, Pacak K.

J Clin Neurosci. 2014 Feb;21(2):256-62. doi: 10.1016/j.jocn.2013.03.036. Epub 2013 Oct 9.

PMID:
24119956
8.

Hospital mortality in primary admissions of septic patients with status epilepticus in the United States*.

Urtecho J, Snapp M, Sperling M, Maltenfort M, Vibbert M, Athar MK, McBride W, Moussouttas M, Bell R, Jallo J, Rincon F.

Crit Care Med. 2013 Aug;41(8):1853-62. doi: 10.1097/CCM.0b013e31828a3994.

PMID:
23782964
9.

Candida cerebral abscesses: a case report and review of the literature.

Fennelly AM, Slenker AK, Murphy LC, Moussouttas M, DeSimone JA.

Med Mycol. 2013 Oct;51(7):779-84. doi: 10.3109/13693786.2013.789566. Epub 2013 May 8. Review.

PMID:
23651179
10.

Association between sympathetic response, neurogenic cardiomyopathy, and venous thromboembolization in patients with primary subarachnoid hemorrhage.

Moussouttas M, Bhatnager M, Huynh TT, Lai EW, Khoury J, Dombrowski K, DeCaro M, Pacak K.

Acta Neurochir (Wien). 2013 Aug;155(8):1501-10. doi: 10.1007/s00701-013-1725-x. Epub 2013 May 1.

PMID:
23636336
11.

Red blood cell transfusion increases the risk of thrombotic events in patients with subarachnoid hemorrhage.

Kumar MA, Boland TA, Baiou M, Moussouttas M, Herman JH, Bell RD, Rosenwasser RH, Kasner SE, Dechant VE.

Neurocrit Care. 2014 Feb;20(1):84-90. doi: 10.1007/s12028-013-9819-0.

PMID:
23423719
12.

Posterior Reversible Encephalopathy Syndrome Presenting as Opsoclonus-Myoclonus.

Boland T, Strause J, Hu M, Santamaria D, Liang TW, Kremens D, Sergott R, Moussouttas M.

Neuroophthalmology. 2012 Oct;36(4):149-152. Epub 2012 Jul 2.

13.

Impact of acute lung injury and acute respiratory distress syndrome after traumatic brain injury in the United States.

Rincon F, Ghosh S, Dey S, Maltenfort M, Vibbert M, Urtecho J, McBride W, Moussouttas M, Bell R, Ratliff JK, Jallo J.

Neurosurgery. 2012 Oct;71(4):795-803.

PMID:
22855028
14.

Prevalence, timing, risk factors, and mechanisms of anterior cerebral artery infarctions following subarachnoid hemorrhage.

Moussouttas M, Boland T, Chang L, Patel A, McCourt J, Maltenfort M.

J Neurol. 2013 Jan;260(1):21-9. doi: 10.1007/s00415-012-6576-5. Epub 2012 Jun 24.

PMID:
22729387
15.

Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage.

Moussouttas M, Lai EW, Khoury J, Huynh TT, Dombrowski K, Pacak K.

Neurocrit Care. 2012 Jun;16(3):381-8. doi: 10.1007/s12028-012-9673-5.

PMID:
22311230
16.

Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.

Moussouttas M.

Ther Adv Neurol Disord. 2012 Jan;5(1):43-56. doi: 10.1177/1756285611422267.

17.

Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage.

Moussouttas M, Huynh TT, Khoury J, Lai EW, Dombrowski K, Pello S, Pacak K.

Cerebrovasc Dis. 2012;33(2):173-81. doi: 10.1159/000334660. Epub 2012 Jan 5.

18.

CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy.

Moussouttas M, Lai EW, Dombrowski K, Huynh TT, Khoury J, Carmona G, DeCaro M, Pacak K.

Neurocrit Care. 2011 Jun;14(3):401-6. doi: 10.1007/s12028-011-9527-6.

PMID:
21409493
19.

Impact of intraventricular hemorrhage upon intracerebral hematoma expansion.

Moussouttas M, Malhotra R, Fernandez L, Maltenfort M, Holowecki M, Delgado J, Lawson N, Badjatia N.

Neurocrit Care. 2011 Feb;14(1):50-4. doi: 10.1007/s12028-010-9452-0.

PMID:
20882367
20.

Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcome.

Mortazavi SM, Kakli H, Bican O, Moussouttas M, Parvizi J, Rothman RH.

J Bone Joint Surg Am. 2010 Sep 1;92(11):2095-101. doi: 10.2106/JBJS.I.00940.

PMID:
20810859
21.

Prevalence of stroke in Restless Legs Syndrome: Initial Results Point to the Need for More Sophisticated Studies.

Walters AS, Moussouttas M, Siddiqui F, Silveira DC, Fuentes K, Wang L, Berger K.

Open Neurol J. 2010 Jun 15;4:73-7. doi: 10.2174/1874205X01004010073.

22.

Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage.

Moussouttas M, Malhotra R, Fernandez L, Maltenfort M, Holowecki M, Delgado J, Lawson N, Badjatia N.

Neurocrit Care. 2010 Feb;12(1):24-9. doi: 10.1007/s12028-009-9290-0.

PMID:
19844810
23.

Thunderclap headache with normal CT and lumbar puncture: further investigations are unnecessary: against.

Moussouttas M, Mayer SA.

Stroke. 2008 Apr;39(4):1394-5. doi: 10.1161/STROKEAHA.107.503169. Epub 2008 Mar 6. Review. No abstract available.

PMID:
18323488
24.

Analysis of the endothelial nitric oxide synthase gene as a modifier of the cerebral response to ischemia.

Dutra AV, Lin HF, Juo SH, Boyadjis M, Moussouttas M, Reddy PL, Grewal RP.

J Stroke Cerebrovasc Dis. 2006 May-Jun;15(3):128-31.

PMID:
17904064
25.

Emerging therapies: ESPRIT.

Moussouttas M.

Stroke. 2007 Apr;38(4):1142. Epub 2007 Feb 15. No abstract available.

PMID:
17303765
26.

Cerebrovascular disease among patients from the Indian subcontinent.

Moussouttas M, Aguilar L, Fuentes K, Anyanwu B, Manassarians H, Papamitsakis N, Shi Q, Visintainer P.

Neurology. 2006 Sep 12;67(5):894-6.

PMID:
16966562
27.

Eclamptic subarachnoid haemorrhage without hypertension.

Moussouttas M, Abubakr A, Grewal RP, Papamitsakis N.

J Clin Neurosci. 2006 May;13(4):474-6.

PMID:
16678728
28.

Metabolic syndrome: contributing factors and treatment strategies.

Fowler SB, Moussouttas M, Mancini B.

J Neurosci Nurs. 2005 Aug;37(4):220-3. Review.

PMID:
16206549
29.

Fulminant acute inflammatory demyelinating polyradiculoneuropathy: case report and literature review.

Moussouttas M, Chandy D, Dyro F.

Neurocrit Care. 2004;1(4):469-73. Review.

PMID:
16174952
30.

Amnestic syndrome of the subcallosal artery: a novel infarct syndrome.

Moussouttas M, Giacino J, Papamitsakis N.

Cerebrovasc Dis. 2005;19(6):410-4. Epub 2005 May 30. No abstract available.

PMID:
15925871
31.

Emerging therapies: clopidogrel and aspirin.

Moussouttas M.

Stroke. 2005 Apr;36(4):707. No abstract available.

PMID:
15800248
32.

Combination antiplatelet agents in ischemic cerebrovascular disease.

Moussouttas M, Papamitsakis N.

Mt Sinai J Med. 2005 Jan;72(1):16-22. Review.

PMID:
15682258
33.

Cannabis use and cerebrovascular disease.

Moussouttas M.

Neurologist. 2004 Jan;10(1):47-53. Review.

PMID:
14720314
34.

Intravascular lymphomatosis presenting as posterior leukoencephalopathy.

Moussouttas M.

Arch Neurol. 2002 Apr;59(4):640-1. No abstract available.

PMID:
11939902
35.

Aortic arch replacement for recurrent cerebral embolization.

Lancaster G, Lovoulos CJ, Moussouttas M, Goldstein AH, Leifer D, Fayad PB, Olsen D, Elefteriades JA.

Ann Thorac Surg. 2002 Jan;73(1):291-4.

PMID:
11834031
36.

Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations.

Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, Ma TY, White RI.

Neurology. 2000 Oct 10;55(7):959-64.

PMID:
11061251
37.

Idiopathic progressive hyalinizing and calcifying CNS vasculopathy.

Moussouttas M, Morgello S, Geraci A, Chan B, Wallace S.

Neurology. 1998 Nov;51(5):1497-9.

PMID:
9818896
38.

Spontaneous internal carotid artery dissection with isolated vagus nerve deficit.

Moussouttas M, Tuhrim S.

Neurology. 1998 Jul;51(1):317-8. No abstract available.

PMID:
9674836

Supplemental Content

Loading ...
Support Center